{"id":"W2143439165","doi":"10.1186/ar2859","title":"Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial","year":2009,"lang":"en","type":"article","venue":"Arthritis Research & Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"ca_institutions":"Mount Sinai Hospital","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Rheumatoid arthritis; Rheumatology; Methotrexate; Internal medicine; Quality of life (healthcare); Physical therapy; Arthritis; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004907113,0.0005270724,0.003745387,0.0007260883,0.0002761737,0.0001559417,0.000232309,0.0002249138,0.0002897251],"category_scores_gemma":[0.005457575,0.0003283985,0.0002930797,0.0008561672,0.001011776,0.0003025233,0.00008256463,0.0008996048,0.000002330696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000160358,"about_ca_system_score_gemma":0.0006584201,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02014449,"about_ca_topic_score_gemma":0.002351508,"domain_scores_codex":[0.9859577,0.006645538,0.003486027,0.0009045945,0.001838941,0.001167234],"domain_scores_gemma":[0.9927077,0.004453813,0.0009532162,0.000800538,0.0005900643,0.0004947224],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7936186,0.001161259,0.0322506,0.00001303365,0.0007250846,0.0001144569,0.004254686,8.646159e-7,0.0002359399,0.0001478257,0.00009852095,0.1673792],"study_design_scores_gemma":[0.9305972,0.006017006,0.05945473,0.0009853942,0.000002834696,0.0000163176,0.001197775,0.0001579435,0.0001245728,0.0008335493,0.0003166921,0.0002959699],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9426823,0.03853627,0.000003282204,0.003784455,0.000053237,0.01436021,0.0001752854,0.00005377579,0.0003511751],"genre_scores_gemma":[0.7975536,0.2012817,0.00009776422,0.0002020159,0.00001632163,0.0006354478,0.0001158474,0.00005026102,0.00004703309],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1670832,"threshold_uncertainty_score":0.9999168,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0424838357597094,"score_gpt":0.3419703894465726,"score_spread":0.2994865536868632,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}